Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Management of Medication Related Osteonecrosis of the Jaws With Double Periosteal Flap Closure

NCT: NCT07177378 · ENROLLING_BY_INVITATION

NCT IDNCT07177378
StatusENROLLING_BY_INVITATION
Start Date2025-01-03
Completion2026-12-26

Brief Summary

20 patients with MRONJ underwent surgical debridement using piezosurgery then closure using double periosteal flap

Frequently Asked Questions

What is Management of Medication Related Osteonecrosis of the Jaws With Double Periosteal Flap Closure?

Management of Medication Related Osteonecrosis of the Jaws With Double Periosteal Flap Closure is a clinical trial registered under NCT07177378. Current status: ENROLLING_BY_INVITATION.

What is the status of NCT07177378?

The current status of NCT07177378 (Management of Medication Related Osteonecrosis of the Jaws With Double Periosteal Flap Closure) is: ENROLLING_BY_INVITATION.

When did Management of Medication Related Osteonecrosis of the Jaws With Double Periosteal Flap Closure start?

Management of Medication Related Osteonecrosis of the Jaws With Double Periosteal Flap Closure started on 2025-01-03.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑